المهام

me: Manal Mousa Ibrahim ElHabbash.

Sex: female

Address: Tripoli medical center/ oncology& hematology department

Tel.0913707033

P.O. Box 83763

Educational attainment:

Date institute place rating

1973-1985 primary &secondary school Libya Excellent

1986-1992 faculty of Medicine Libya very good

Tripoli University

Tripoli / Libya

Qualification:

January 1992 M.B.B.Ch very good

December 1994 Arab Board part 1

October 1996 Libyan Board part 1

March 1998 Arab Board of internal Medicine part II

November 1999 Libyan Board of internal Medicine part II

October 2000 Libyan Board of oncology and radiotherapy part I

May1998-april 1999 course in Physiotherapy

March 1997-oct. 1997 course in Hemodialysis

المسيرة المهنية

April 1992 -march 1993 internship University hospital

Department of general surgery. 6 months Tripoli Central Hospital.

Department of Medicine.

April 1993- Oct. 1995 S.H.O Tripoli Central Hospital.

Department of Medicine

Oncology unit.

Oct.1995-Dec 1996 S.H.O Tripoli Central Hospital

Department of Medicine

ICU unit.

Jan.1997-april 1997 Registrar Tripoli Medical Center

Respiratory unit.

May 1997- April 1998 Registrar Tripoli Medical Center

Cardiology unit.

May 1998- Jan 1999 Senior registrar Tripoli Medical Center

Pediatric hematology

&

Jun.1999-till date Consultant Tripoli Medical Center

Hematology and Oncology Department

Jan 1013till date head of unit A Tripoli Medical Center

Hematology & oncology department.

Internal Medicine department Lecturer from 1/2008 till 1/2011.

1/2011-1/2015 assistant professor Tripoli University Internal Medicine

department,

From 1/2019 till date professor of internal medicine, faculty of medicine, Tripoli

university.

**Member of European society of medical oncology

Member of European hematology association

Member of American society of clinical oncology.

الاهتمامات البحثية

1-Publication of Dermatofibrosarcoma protuberans

A. Alwindi, ElHabbash M, Khalil ElHabbash.

Accepted as oral presentation in the 4th international Medical

Conference.

2-Epidemiology, clinical feature and survival of breast cancer

Patient in Tripoli 1990-1999.

ElHabbash M, A. Alwindi.

First international conference of oncology, 26-28 May 2000.

Published in JMJ Spring 2006, Vol.5, and No: 1 page 42-46.

3-Adjuvant Tamoxifen in breast cancer patients of unknown receptor

Status, ElHabbash M, A. Alwindi.

First international conference in Libya 2000. & St Gallen

International Breast Cancer conference in Switzerland 2003.

Published in JMJ Spring 2006, Vol.5, and No: 1 page 42-46.

4-Epidemiology of Multiple Myeloma and survival rate in Tripoli

1991-2000, ElHabbash in 2nd international conference of oncology in Libya 2/2002.

In 2nd congress Maghrebin hematology conference May 2005.

5-Paclitaxel in relapsed high risk Anthracycline treated breast

Cancer Patient. ElHabbash M , A.Alwindi

Saudi Medical Journal volume 26 No.9:2005, page 1471-1473.

&Presented in 7th Milan Breast cancer.

6-Amyloidosis in Waldenstrom’s Macroglobulinemia

E Sassi, M ElHabbash.

Published in JMJ, Sept.2002. vol. 2, no: 2.page 85-86.

7- Behavior of Sickle cell anemia and its management in adult

Patients. ElHabbash M , A.Alwindi, Marwa Gamra.

3rd Magrabian Hematology conference in 2-4th July 2006.

8-survival of breast cancer in women <35 years

ElHabbash M, A. Alwindi, EBCC-6 15-19 April 2008 EJC abstract book suppl. Vol. 6 No 7.

4th cancer conference of the African Oncology Institute 22-25th Jan 2009 Subratha –Libya.

9- TMC experience in Aplastic Anemia, ElHabbash M. A. Elturki, N. Jurnaz.

in JMJ summer 2008, Vol.8, and No: 2 page 101-104. 4th Magrabian Hematology conference

in 2007.

10-survival of breast cancer treated in Tripoli /Libya 2000-2005

ElHabbash M, A. Alwindi, St Gallen International Breast Cancer conference in Switzerland,

2007 poster 156 (The Breast suppl.Vol.16). 3rd cancer conference of the African Oncology

Institute 19-21 Jan 2007 Subratha –Libya. Accepted in JMJ, March 2009.

11- Survival in breast cancer with bone metastases. ElHabbash M, A. Alwindi

St Gallen International Breast Cancer conference in Switzerland

2007 poster 157 (The Breast suppl.Vol.16).3rd cancer conference of the African Oncology

Institute 19-21 Jan. 2007 Subratha –Libya.

12- Progress in Immunotherapy (Rituximab) Review article ElHabbash M, A. Alwindi

Saudi Medical Journal volume 28 No.11:2007, page 1635-1644.

13- Male breast cancer in Tripoli /Libya, ElHabbash M, A. Alwindi

4th cancer conference of the African Oncology Institute 22-25th, Jan. 2009 Subratha –Libya. St

Gallen International Breast Cancer conference in Switzerland 2009poster232.The Breast Suppl.

Accepted in SMJ2009. Saudi Medical Journal.

14- Iron deficiency anemia and latent iron deficiency among young female medical students. M.

El-Habbash, A. Alwindi, F. Alkhanshoush. in 6th international conference of oncology in Libya

3/2009.Published in Libyan Medical Journal 2012.

15- Breast cancer in Tripoli /Libya1990-2008 as publication in

ASCO 2010 e 12052.

16-triple negative breast cancer in Libya published in St Gallen

International breast cancer conference.2013.

17-rituximab in non-Hodgkin lymphoma, Pan Arab Journal of

Oncology. June 2015.

18-Bilateral breast cancer in Libya. Manal ElHabbash, pan Arab

Journal of Oncology. March 2017.

19-Rituximab therapy in chronic idiopathic thrombocytopenic

Purpura. Manal ElHabbash, International Annals of Medicine(IAM)march2018.

20-Relation of Iron Deficiency Anemia and the level of hemoglobin. (HbA1c) in non diabetic

patients. Manal ElHabbash, IAM June 2018.

21-Behavior of sickle cell disease and its management in adults

patients. Manal ElHabbash, International Annals of Medicine(IAM). August 2018.

النشاطات الخارجية

مراجع في المجلة السعودية 

مراجع للمجلة العمانية الطبية 

اشراف رسائل ماجستير